Affordable Access

Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent.

Authors
Type
Published Article
Journal
Current cancer drug targets
Publication Date
Volume
10
Issue
4
Pages
368–383
Identifiers
PMID: 20464779
Source
Medline

Abstract

Statistics

Seen <100 times